Use of anti-hepatitis C virus seropositive organs in liver transplantation.
Mulligan
D C
DC
Division of Transplantation Services, Baylor University Medical Center, Dallas, Texas 75246.
Goldstein
R M
RM
Crippin
J S
JS
Abouljoud
M S
MS
Levy
M F
MF
Husberg
B S
BS
Gonwa
T A
TA
Foster
B R
BR
Tillery
G W
GW
Klintmalm
G B
GB
D000704:Analysis of Variance; D005260:Female; D005500:Follow-Up Studies; D016174:Hepacivirus / Q000302:isolation & purification*; D006526:Hepatitis C / Q000453:epidemiology*; D006801:Humans; D008099:Liver / Q000473:pathology / Q000821:virology*; D016031:Liver Transplantation / Q000401:mortality / Q000473:pathology / Q000502:physiology*; D008297:Male; D011183:Postoperative Complications / Q000453:epidemiology*; D011336:Probability; D012008:Recurrence; D012307:Risk Factors; D015996:Survival Rate; D013997:Time Factors